Breaking News Instant updates and real-time market news.

MCK

McKesson

$141.44

-0.6 (-0.42%)

08:23
05/19/17
05/19
08:23
05/19/17
08:23

McKesson earnings beat low quality, says Leerink

Leerink analyst David Larsen views McKesson's earnings beat in Q4 as low quality since most of the upside came from a lower tax rate and lower share count. Excluding these two items, the company would have missed consensus by 4c, Larsen tells investors in a research note. While the initial FY18 earnings outlook looks good, management changed the definition of adjusted earnings, the analyst adds. The analyst believes the earnings outlook of $11.75-$12.45 would have been $1.30 lower had the definition not been changed. The business, however, appears to be stabilizing, Larsen adds. He keeps a Market Perform rating on McKesson with a $140 price target.

  • 24

    May

  • 26

    May

MCK McKesson
$141.44

-0.6 (-0.42%)

04/21/17
LEER
04/21/17
NO CHANGE
Target $140
LEER
Market Perform
McKesson price target lowered to $140 from $155 at Leerink
Leerink analyst David Larsen lowered his price target for McKesson to $140 from $155 ahead of Q4 results and 2018 guide as the analyst is incrementally more cautious on the stock following the company's pre-announcement. Larsen reiterates a Market Perform rating on the shares.
05/11/17
WELS
05/11/17
NO CHANGE
WELS
Market Perform
Teva faces 'underappreciated risk' from major generic RFPs, says Wells Fargo
Wells Fargo analyst David Maris noted that Teva's generic drug price erosion came in at 7% in Q1, adding that Teva's management, which previously indicated that they expected price erosion in the U.S. to be 5%, "did not explain well" how the factors that negatively impacted prices were not fully anticipated. Also, there are currently two major generic Request for Proposals out for bid - one from Express Scripts (ESRX), Albertson's and Kroger (KR) and one from Walmart (WMT) and McKesson (MCK) - and the potential price reset from these is an "underappreciated risk" facing Teva, added Maris, who keeps a Market Perform rating on the stock.
05/17/17
JEFF
05/17/17
INITIATION
Target $153
JEFF
Hold
McKesson initiated with a Hold at Jefferies
Jefferies analyst Brian Tanquilut started McKesson with a Hold rating and $153 price target. The analyst expects accelerating generic drug price deflation and moderating brand drug inflation will continue to pressure the company's growth.
05/19/17
JEFF
05/19/17
NO CHANGE
Target $153
JEFF
Hold
McKesson FY18 guidance is below consensus, says Jefferies
Jefferies analyst Brian Tanquilut says that while McKesson's FY18 guidance came in above consensus on the surface, a deeper look suggests that absent a $200M deferred revenue adjustment for Change Healthcare and a lower tax rate, the apples-to-apples comparison was an earnings per share outlook of $10.81-$11.51 versus the $11.45 consensus. On an apples-to-apples basis, the earnings guidance is below consensus, Tanquilut tells investors in a post-earnings research note. He keeps a Hold rating on McKesson. The stock in premarket trading is up 8% to $153.00.

TODAY'S FREE FLY STORIES

VLO

Valero

$67.78

0.26 (0.39%)

, PSX

Phillips 66

$82.85

0.49 (0.59%)

06:28
07/24/17
07/24
06:28
07/24/17
06:28
Periodicals
U.S. mulls financial sanctions on Venezuela's PDVSA, Reuters reports »

The Trump administration…

VLO

Valero

$67.78

0.26 (0.39%)

PSX

Phillips 66

$82.85

0.49 (0.59%)

CVX

Chevron

$103.25

-1.38 (-1.32%)

PBF

PBF Energy

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 27

    Jul

  • 28

    Jul

  • 01

    Aug

  • 03

    Aug

KCDMY

Kimberly-Clark de Mexico

$10.34

-0.3 (-2.82%)

06:28
07/24/17
07/24
06:28
07/24/17
06:28
Upgrade
Kimberly-Clark de Mexico rating change  »

Kimberly-Clark de Mexico…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

PPG

PPG

$106.37

-0.35 (-0.33%)

06:28
07/24/17
07/24
06:28
07/24/17
06:28
Downgrade
PPG rating change  »

PPG downgraded to Hold…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

FND

Floor & Decor

$37.40

-1.1 (-2.86%)

06:28
07/24/17
07/24
06:28
07/24/17
06:28
Upgrade
Floor & Decor rating change  »

Floor & Decor…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 27

    Jul

BABA

Alibaba

$151.89

-0.22 (-0.14%)

, MGI

MoneyGram

$16.56

-0.28 (-1.66%)

06:26
07/24/17
07/24
06:26
07/24/17
06:26
Periodicals
Smith says U.S. should block Ant, MoneyGram deal, NY Post reports »

Rep. Chris Smith, the…

BABA

Alibaba

$151.89

-0.22 (-0.14%)

MGI

MoneyGram

$16.56

-0.28 (-1.66%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

MRSN

Mersana Therapeutics

$14.05

-0.14 (-0.99%)

06:25
07/24/17
07/24
06:25
07/24/17
06:25
Initiation
Mersana Therapeutics initiated  »

Mersana Therapeutics…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

MTZ

MasTec

$45.30

-0.35 (-0.77%)

06:25
07/24/17
07/24
06:25
07/24/17
06:25
Upgrade
MasTec rating change  »

MasTec upgraded to…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 04

    Aug

WFC

Wells Fargo

$54.17

-0.71 (-1.29%)

06:23
07/24/17
07/24
06:23
07/24/17
06:23
Hot Stocks
Wells Fargo ordered to reinstate whistleblower, pay $577K in back wages, damages »

The U.S. Department of…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 12

    Oct

  • 15

    Jan

MIK

Michaels

$19.02

0.22 (1.17%)

06:23
07/24/17
07/24
06:23
07/24/17
06:23
Upgrade
Michaels rating change  »

Michaels upgraded to…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

MRSN

Mersana Therapeutics

$14.05

-0.14 (-0.99%)

06:21
07/24/17
07/24
06:21
07/24/17
06:21
Initiation
Mersana Therapeutics initiated  »

Mersana Therapeutics…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

C

Citi

$66.00

-0.36 (-0.54%)

06:21
07/24/17
07/24
06:21
07/24/17
06:21
Conference/Events
Citi to host investor day »

Investor Day to be held…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 25

    Jul

SFTBF

SoftBank

$82.90

-0.25 (-0.30%)

06:20
07/24/17
07/24
06:20
07/24/17
06:20
Periodicals
Didi Chuxing, SoftBank to invest $2B in ride-hail startup Grab, Recode says »

Chinese ride-hailing…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

BHF

Brighthouse Financial

, MET

MetLife

$54.65

0.07 (0.13%)

06:20
07/24/17
07/24
06:20
07/24/17
06:20
Initiation
Brighthouse Financial, MetLife initiated  »

Brighthouse Financial…

BHF

Brighthouse Financial

MET

MetLife

$54.65

0.07 (0.13%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 03

    Aug

  • 14

    Aug

  • 15

    Aug

ACM

Aecom

$32.02

-0.25 (-0.77%)

06:19
07/24/17
07/24
06:19
07/24/17
06:19
Downgrade
Aecom rating change  »

Aecom downgraded to…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 08

    Aug

TEVA

Teva

$32.64

0.21 (0.65%)

06:18
07/24/17
07/24
06:18
07/24/17
06:18
Periodicals
Teva to cut Israeli workforce, mainly in production, Reuters reports »

Teva is planning to cut…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 03

    Aug

  • 30

    Aug

INTU

Intuit

$134.84

-0.51 (-0.38%)

06:17
07/24/17
07/24
06:17
07/24/17
06:17
Conference/Events
Intuit management to meet with Northcoast »

Meeting to be held in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 24

    Jul

CBI

CB&I

$17.79

-0.34 (-1.88%)

06:15
07/24/17
07/24
06:15
07/24/17
06:15
Downgrade
CB&I rating change  »

CB&I downgraded to…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 07

    Aug

ZEN

Zendesk

$29.16

-0.04 (-0.14%)

06:15
07/24/17
07/24
06:15
07/24/17
06:15
Recommendations
Zendesk analyst commentary  »

Piper remains buyer of…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 03

    Aug

  • 05

    Sep

PM

Philip Morris

$119.58

-0.28 (-0.23%)

06:13
07/24/17
07/24
06:13
07/24/17
06:13
Periodicals
India to seek explanation from Philip Morris on Marlboro marketing, Reuters says »

India is planning to quiz…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

GOOG

Alphabet

$972.92

4.77 (0.49%)

, GOOGL

Alphabet Class A

$993.84

1.65 (0.17%)

06:13
07/24/17
07/24
06:13
07/24/17
06:13
Periodicals
Google, meida companies running tests to detect spoofing, BI reports »

Google (GOOG, GOOGL) and…

GOOG

Alphabet

$972.92

4.77 (0.49%)

GOOGL

Alphabet Class A

$993.84

1.65 (0.17%)

CBS

CBS

$65.83

-0.03 (-0.05%)

CMCSA

Comcast

$39.63

0.14 (0.35%)

CMCSK

Comcast

NYT

New York Times

$18.10

0.05 (0.28%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 24

    Jul

  • 27

    Jul

  • 27

    Jul

  • 07

    Sep

GS

Goldman Sachs

$220.18

-2.12 (-0.95%)

, MS

Morgan Stanley

$46.59

0.08 (0.17%)

06:11
07/24/17
07/24
06:11
07/24/17
06:11
Downgrade
Goldman Sachs, Morgan Stanley rating change  »

Goldman Sachs downgraded…

GS

Goldman Sachs

$220.18

-2.12 (-0.95%)

MS

Morgan Stanley

$46.59

0.08 (0.17%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 01

    Aug

  • 01

    Aug

  • 17

    Oct

MRSN

Mersana Therapeutics

$14.05

-0.14 (-0.99%)

06:10
07/24/17
07/24
06:10
07/24/17
06:10
Initiation
Mersana Therapeutics initiated  »

Mersana Therapeutics…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

NSRGY

Nestle

$87.60

-0.09 (-0.10%)

06:10
07/24/17
07/24
06:10
07/24/17
06:10
Periodicals
Ferrara Candy eyeing Nestle's U.S. candy business, Reuters reports »

Lemonheads and Now &…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

WIX

Wix.com

$73.10

-0.1 (-0.14%)

06:07
07/24/17
07/24
06:07
07/24/17
06:07
Initiation
Wix.com initiated  »

Wix.com initiated with an…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 27

    Jul

  • 08

    Aug

APRN

Blue Apron

$6.55

0.03 (0.46%)

06:07
07/24/17
07/24
06:07
07/24/17
06:07
Initiation
Blue Apron initiated  »

Blue Apron initiated with…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 10

    Aug

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.